Replies to post #5749 on SiNtx Technologies Inc (SINT)

[BiotechValues]

Thanks- I'll ask about autologous stem cells also.

I added more here at .67.

Bottom in I'd say. P/S well below 1 and near term financing in place. As a biotech stock, I see no reason for this to go any lower.

Risk from shorting (which has its place many times), appears too great.